Published in AIDS Weekly, February 9th, 1998
The University of Pennsylvania researchers said they hoped a vaccine would work better in people who had the virus under control.
They said they would test 21 people who were taking the drugs. They would use various doses of a vaccine developed by Apollon Inc., Malvern, Pennsylvania.
"We think we can get an enhanced response to the DNA vaccine in conditions where the immune system is not preoccupied simply with maintaining itself against an HIV infection," Dr. Rob Roy...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1998-02-09)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.